In line with these findings, we noticed a positive correlation between parameters of DM progression (glycemia, HbA1c) and concentrations of Th1- and Th17-related cytokines in the serum samples of DM patients who continuously used CCs. This evidence concerns the gene NELFCD and dermatomyositis.